Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore (A1605, APExBIO) is a cell-permeable, reversible, and noncompetitive inhibitor of dynamin GTPases, with an IC₅₀ of 15 μM for dynamin1. It disrupts dynamin-dependent endocytosis, including clathrin-mediated pathways, in diverse cell types (Wang et al. 2018, DOI). Dynasore blocks transferrin and synaptic vesicle uptake, enabling researchers to dissect vesicle trafficking and synaptic function. The compound is soluble in DMSO (≥16.12 mg/mL), but insoluble in water and ethanol, and should be stored at −20°C. Widely used in cancer, neurodegeneration, and infectious disease models, Dynasore provides a benchmark pharmacological approach for endocytosis research (internal ref).

Biological Rationale

Dynamin GTPases are critical for membrane fission events during clathrin-mediated endocytosis, vesicle trafficking, signal transduction, and protein translocation. These enzymes, including dynamin1 (neuronal), dynamin2 (ubiquitous), and Drp1 (mitochondrial), hydrolyze GTP to drive vesicle scission. Disrupting dynamin activity provides mechanistic insight into vesicle trafficking, receptor internalization, and synaptic vesicle recycling. Pathways regulated by dynamin are implicated in cancer, neurodegenerative disease, and viral entry. Pharmacological inhibition of dynamin, as achieved with Dynasore, enables precise temporal control over endocytic processes, unlike genetic knockouts, which may cause compensatory changes or lethality (compare: protocol-focused review).

Mechanism of Action of Dynasore

Dynasore is a small-molecule inhibitor that acts noncompetitively on the GTPase activity of dynamin1, dynamin2, and Drp1. It binds to a site distinct from the GTP binding pocket, inhibiting GTP hydrolysis required for dynamin-driven membrane fission. In vitro, Dynasore exhibits an IC₅₀ of 15 μM for dynamin1 (APExBIO). The inhibition is rapid, reversible, and does not require covalent modification of the enzyme. Dynasore also blocks endocytic vesicle formation in living cells, as evidenced by suppression of transferrin uptake and synaptic vesicle recycling in HL-1 cells and neurons. Importantly, Dynasore does not impede endocytosis through dynamin-independent mechanisms, supporting its specificity in most cellular contexts (Wang et al. 2018).

Evidence & Benchmarks

• Dynasore inhibits dynamin1 GTPase activity with an IC₅₀ of 15 μM under in vitro conditions (buffer pH 7.4, 25°C) (APExBIO product page).
• Blocks clathrin-mediated endocytosis and viral entry in grass carp kidney (CIK) cells, as measured by reduced GCRV104 infection, when pre-incubated at 80 μM (Wang et al. 2018, DOI).
• Suppresses transferrin uptake and synaptic vesicle endocytosis in neuronal and cardiac cell models within 5–15 minutes of application (internal review).
• Reversible inhibition observed; washout restores endocytosis within minutes in cell-based assays (internal article).
• No significant inhibition of dynamin-independent endocytosis (e.g., caveolin-mediated) under standard protocols (Wang et al. 2018).

Applications, Limits & Misconceptions

Dynasore is widely used for:

• Dissecting clathrin-mediated endocytosis and vesicle trafficking pathways.
• Studying synaptic vesicle recycling, especially in neurons and HL-1 cardiac cells.
• Modeling viral entry mechanisms dependent on dynamin, as in studies of GCRV104 infection (Wang 2018).
• Probing signal transduction and protein biosynthesis pathways regulated by endocytosis (compare: translational science focus).
• Enabling rapid, reversible inhibition for high temporal-resolution studies, distinct from genetic knockdown models.

Common Pitfalls or Misconceptions

• Dynasore is not effective for caveolin- or clathrin-independent endocytosis. It specifically targets dynamin-dependent mechanisms (Wang et al. 2018).
• Water and ethanol are unsuitable solvents. Dynasore is insoluble in both; use DMSO at ≥16.12 mg/mL (APExBIO).
• Prolonged exposure or high concentrations may cause off-target effects. Use minimal effective dose and include vehicle controls in experiments (internal troubleshooting).
• Not suitable for in vivo diagnostic or therapeutic use. Dynasore is strictly for scientific research (APExBIO).
• Washout is required for reversibility. Residual Dynasore can continue to inhibit dynamin activity unless thoroughly removed (internal workflow guide).

Workflow Integration & Parameters

For experimental reproducibility, dissolve Dynasore in DMSO at ≥16.12 mg/mL. Warm at 37°C or sonicate to accelerate dissolution. Prepare fresh working solutions before each experiment. Store stock solutions at −20°C for up to several months. Typical working concentrations range from 10 to 80 μM, depending on cell type and endpoint. Apply directly to culture media; include DMSO-only controls to rule out solvent effects. For reversibility studies, wash cells thoroughly (e.g., 3× with PBS) to remove Dynasore and monitor endocytosis recovery. Confirm inhibition using transferrin or dextran uptake assays.

The APExBIO A1605 kit provides quality-controlled Dynasore suitable for rigorous cell biology workflows.

Conclusion & Outlook

Dynasore remains a cornerstone tool for probing dynamin GTPase signaling and vesicle trafficking pathways in cell biology, cancer, and neurodegenerative disease models. Its rapid, reversible, and specific inhibition profile enables high-resolution dissection of endocytic events. By leveraging Dynasore in parallel with genetic tools and orthogonal inhibitors, researchers can achieve robust, mechanistically precise insights into cellular uptake and trafficking. For advanced applications and troubleshooting, see this workflow guide (which details troubleshooting and advanced uses beyond this article's scope). Together with internal references, this article clarifies the experimental parameters, limits, and mechanistic rationale for Dynasore, supporting reproducible and interpretable endocytosis research.